Wednesday, May 06, 2020 8:47:10 AM
Thanks Nick.
Go Leo & IPIX!
In response too.
IMO the additional MTA is for the purposes of Brilacidin to be utilized as an adjunct immunomodulator for a vaccine. It’s why they stated dosing needed for young and old. The young have been mostly spared, thank god, so this points to a vaccine since everyone would get the vaccine both young and old so we don’t have silent carriers through the young moving forward. If this MTA was for a treatment then they wouldn’t have requested young samples as well. I’ll explain further.
An immunomodulator (Brilacidin) is an artificial antibody used to regulate immune mediators (T cells, B cells, monocytes, etc.) in your system.
Immune mediators are the cells in your body that go to war against foreign substances(COVID-19). They are also what provides the symptoms like inflammation, fever, headache, etc... The problem with COVID-19 is that our natural defenses (immune mediators) attack so strongly that it causes massive inflammation throughout the body which is the leading cause of COVID complications.
You can’t just take halfway dead COVID virus cells and Inject them into the body (like first early vaccines) because our immune mediators will react in the same way and give the negative effects that are killing people therefore if there were an immunomodulator as an adjunct to the halfway dead COVID cells then the immunomodulator (Brilacidin) can help keep the immune mediators in check while they fight the half dead COVID-19 while natural antibodies are created from the vaccine without symptoms.
That’s my take to this additional MTA and the scientific analysis of it.
I tried my best to take something very scientific for all to understand. Sorry if it’s still confusing.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
FEATURED Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • Oct 1, 2024 8:30 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM